Evidence map›Paper›PMID 31601915›Full record

ArticleScientific reports2019

Dysregulated liver lipid metabolism and innate immunity associated with hepatic steatosis in neonatal BBdp rats and NOD mice.

D Serrano, J A Crookshank, B S Morgan, R W Mueller, M-F Paré, L Marandi, P Poussier, F W Scott

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

D SerranoChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
J A CrookshankChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
B S MorganChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
R W MuellerDepartment of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
M-F ParéChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
L MarandiSunnybrook Research Institute, Toronto, Ontario, Canada.
P PoussierSunnybrook Research Institute, Toronto, Ontario, Canada.
F W ScottChronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. fscott@ohri.ca.
Ottawa Hospital Research InstituteUniversity of Ottawa · CAOttawa Hospital · CASunnybrook Hospital · CASunnybrook Research Institute

Funding

CIHR EC 2144622CIHR MOP-130485CIHR MOP-148581CIHR MOP-79531
6 · The paper itself

Abstract

In a previous study we reported that prediabetic rats have a unique gene signature that was apparent even in neonates. Several of the changes we observed, including enhanced expression of pro-inflammatory genes and dysregulated UPR and metabolism genes were first observed in the liver followed by the pancreas. In the present study we investigated further early changes in hepatic innate immunity and metabolism in two models of type 1 diabetes (T1D), the BBdp rat and NOD mouse. There was a striking increase in lipid deposits in liver, particularly in neonatal BBdp rats, with a less striking but significant increase in neonatal NOD mice in association with dysregulated expression of lipid metabolism genes. This was associated with a decreased number of extramedullary hematopoietic clusters as well as CD68

Indexed as

Immunity, InnateLipid MetabolismAnimalsAnimals, NewbornAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeDiabetes Mellitus, Type 1Disease Models, AnimalFatty LiverFemaleGene Expression ProfilingLiverMaleMiceMice, Inbred C57BLAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeCD68 protein, mouseTriglycerides

Identifiers

PMID31601915
PMCPMC6787248
OpenAlexW2979319169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.